Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/12968
Title: Identification of telomere dysfunction in Friedreich ataxia.
Authors: Anjomani-Virmouni, S
Al-Mahdawi, S
Sandi, S
Yasaei, H
Giunti, P
Slijepcevic, P
Pook, M
Keywords: Friedreich ataxia;FRDA;Frataxin;FXN;GAA repeat expansion;Mouse model;Alternative lengthening of telomeres;ALT;Telomere dysfunction
Issue Date: 2015
Publisher: Biomed Central
Citation: Molecular Neurodegeneration, 10:22, (2015)
Abstract: Background: Friedreich ataxia (FRDA) is a progressive inherited neurodegenerative disorder caused by mutation of the FXN gene, resulting in decreased frataxin expression, mitochondrial dysfunction and oxidative stress. A recent study has identified shorter telomeres in FRDA patient leukocytes as a possible disease biomarker. Results: Here we aimed to investigate both telomere structure and function in FRDA cells. Our results confirmed telomere shortening in FRDA patient leukocytes and identified similar telomere shortening in FRDA patient autopsy cerebellar tissues. However, FRDA fibroblasts showed significantly longer telomeres at early passage, occurring in the absence of telomerase activity, but with activation of an alternative lengthening of telomeres (ALT)-like mechanism. These cells also showed accelerated telomere shortening as population doubling increases. Furthermore, telomere dysfunction-induced foci (TIF) analysis revealed that FRDA fibroblasts have dysfunctional telomeres. Conclusions: Our finding of dysfunctional telomeres in FRDA cells provides further insight into FRDA molecular disease mechanisms, which may have implications for future FRDA therapy.
URI: http://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-015-0019-6
http://bura.brunel.ac.uk/handle/2438/12968
DOI: http://dx.doi.org/10.1186/s13024-015-0019-6
ISSN: 1750-1326
Appears in Collections:Publications

Files in This Item:
File Description SizeFormat 
Fulltext.pdf2.96 MBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.